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ABSTRACT 
Brain metastasis derived from abdominal neuroblastoma are an uncommon complication of 
this tumour; however, an increase of their incidence has been recently reported. In this study, 
we have investigated the influence of factors derived from CNS glial cells  on human 
neuroblastoma cells (SH-SY5Y) proliferation "in vitro". Co-culture experiments show that a 
24 h exposure to factors released by type 1 astrocytes (A1) may induce a significant decrease 
of [3H]thymidine ([3H]TdR) incorporation in SH-SY5Y cells. This effect was not duplicated 
by fresh A1-conditioned medium (A1-CM); A1-CM become active only when it was heated or 
frozen. In contrast with this short-lived inhibitory effect, a long-term treatment (3, 6, and 9 
days) with A1-CM produces a significant and dose-dependent increase of SH-SY5Y cell 
number. Immunoneutralisation of A1-CM with an anti-TGFß antibody eliminates the 
inhibitory effect on [3H]TdR uptake in SH-SY5Y cells, but it does not affect the increased 
number of viable cells observed after long term treatments.  
In conclusion, these results show that factor(s) released by A1 may affect the 
proliferation/survival of a human neuroblastoma cell line "in vitro" inducing: a) a short 
transient negative effect on DNA synthesis; and b) an overall sustained trophic action. These 
results are suggestive of a possible role of glial cells in the establishment of brain metastases 
of neuroblastomas. 
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INTRODUCTION 
 
Neuroblastomas are solid tumours of childhood characterised by an undifferentiated cell 
phenotypes and a poor prognosis. Occasionally, these tumours show spontaneous regressions 
due to their differentiation into benign ganglioneuromas. Unfortunately, the mechanisms 
which drive this differentiation are still poorly understood. The neuroblastoma is usually 
detected as a solid abdominal mass with diffuse metastasis, although invasion of brain tissue 
was believed to be a rare manifestation of extra- or intra-cranial neuroblastoma. However, it 
has recently reported that 68% of patients affected by neuroblastoma or ganglioneuroblastoma 
suffer of neurological complications due to undiagnosed or hidden brain metastases (Weyl-
Ben Arush et al., 1995; Tasdemiroglu and Patchell, 1997). These lesions may appear as a 
relapse after chemotherapy, and they may become evident after the disappearance of tumoral 
tissue from the usual localisation(Shaw and Eden, 1992; Astigarra et al., 1996; Bouffet et al., 
1997; Lydaki et al., 1997).   
The nervous system is composed of different types of cells which include, in addition to 
neurons, also glial elements (e.g., astrocytes, oligodendrocytes, Schwann cells, etc.). In the last 
few years, it became evident that glial cells may play a relevant role in modulating several 
neuronal functions. Glia-neuron interactions were shown to control neuronal migration and 
differentiation, to provide spatial and metabolic support to neurons, and to modulate their 
synaptic activity (Banker, 1980; Lindsay, 1987; Hatten and Mason, 1990; LoPachin and 
Aschner, 1993). Glial cells, and astrocytes in particular, were found to release many factors 
(e.g., neurotransmitters, neuropeptides, cytokines, growth factors, etc.) known to possess 
trophic or differentiating activities on neuronal and non-neuronal cells (Giulian et al., 1988; 
Muller et al., 1995). Consequently, the establishment of brain metastases of tumoral cells 
might also depend, at least in part, on the trophic support provided by glial elements.  
Many studies have shown that the conditioned media (CM) in which glial cell were growth 
may generally induce neuritogenesis and a neuron-like morphological differentiation of 
neuroblastoma cells. Even though these results appear in apparent contrast with the possibility 
of an establishment of brain metastases of these tumours, the data concerning the effects of 
secretory products of the glial cells on the proliferation of neuroblastoma cells (Monard et al., 
1973; Kato et al., 1983; Sakazaki et al., 1983; Lim et al., 1990; Amano et al., 1994) appear 
sometime incomplete. The reasons of such discrepancies may reside in the different 
experimental conditions adopted. For instance, a number of these studies have been performed 
using the CM obtained from tumoral glial cells (e.g., glioma cells) rather than from 
untransformed astrocytes; moreover, it has recently reported that the glial factors involved in 
the differentiation and neuritogenesis of neuroblastoma cells are apparently released only from 
young and sub-confluent astrocytes (Shea et al., 1994). On the other  
4 
, the presence of brain metastases may be suggestive of a possible role of the glial elements on 
the survival and/or proliferation of neuroblastoma cells. Also considering that astrocytes "in 
vitro" may behave differently from those "in vivo", the utilisation of cells obtained from 
primary cultures may give useful information on the trophic factors physiologically produced 
and released by these glial cells. Therefore, the aim of the present study was to investigate 
whether cultures of neonatal type 1 astrocytes, might produce and release "in vitro" some 
factor(s) which might exert trophic activity on neuroblastoma cells. 
The experiments have been conducted using the human neuroblastoma cell line SH-SY5Y 
(Biedler et al., 1973); these cells have been subcloned from the parental SK-N-SH cell line, 
obtained from a bone marrow metastasis of a neuroblastoma, and have been previously 
extensively characterised (Pahlman et al., 1990). 
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MATERIALS AND METHODS 
 
Cell cultures 
Primary cultures of type 1 and type 2 astrocytes were obtained from the cerebral cortex of 1- to 
2-day old rats as previously described (Melcangi et al., 1993). Human SH-SY5Y 
neuroblastoma cells (kindly provided by Dr. June Biedler, Memorial Sloan-Kettering Cancer 
Center, New York) were derived from the parental SK-N-SH cell line which was established 
from a bone marrow metastasis of a 4-year old girl (Biedler et al., 1973). The cells were grown 
at 37°C in a humidified CO2 incubator in Minimum Essential Medium supplemented with 
non-essential aminoacids, 1 mM sodium pyruvate, 100 µg streptomycin/ml, 100 UI 
penicillin/ml, 10 mg/l of phenol red (Biochrom KG, Berlin, Germany) and 10% foetal bovine 
serum (FBS, Gibco, Grand Island, NY). Confluent cells were harvested with 0.05/0.02% 
trypsin/EDTA and 1.106 cells were seeded in 57 cm2 dishes. The medium was replaced at 2-
day intervals. 
The neutralising pan-specific anti-TGFß antibody (directed to r(h)TGFß1, 1.2, 2, 3 and 5; 
R&D System, Minneapolis; cat.# AB-100-NA) was diluted according to the manufacturer's 
instructions. 
Collection of conditioned media Glial cells were grown in Dulbecco's Modified Eagle's 
Medium (DMEM; Biochrom, KG, Berlin, Germany), supplemented with 10% FBS, 100 µg 
streptomycin/ml and 100 UI penicillin/ml (Melcangi et al., 1993), until confluence was 
reached. To avoid interferences due to factors present in the FBS, the culture medium was 
replaced with Sato's chemical-defined medium (DMEM supplemented with 5 µg/ml bovine 
insulin, 50 µg/ml human transferrin, 20 nM progesterone, 100 µM putrescine dihydrochloride, 
30 nM sodium selenite (Sigma Chemicals, St.Louis, MO) and the cell cultures were returned 
in the incubator; the medium (conditioned medium, CM) was collected 24 hours later and used 
immediately or stored at -20°C as described in the Result section. Sato's medium left in the 
incubator for 24 hours and stored as the CM was used as control. 
Co-culture experiments  Neuroblastoma cells were plated in 6-well tissue culture plates, while 
type 1 astrocytes were plated in 25mm cell culture insert (Falcon, Becton Dickinson Labware, 
England). The bottom of the insert is an opaque membrane, with a pore size of 0.45 µm which 
is specifically designed to provide independent access of the medium to both sides of the 
membrane. Cell culture inserts containing confluent purified type 1 astrocytes at 95% 
confluence were transferred to wells in which neuroblastoma cells were plated 24 h before. At 
the same time the medium was replaced with fresh Sato's defined medium .  
Neuroblastoma cells cultured alone in 6-well plate and pure type 1 astrocytes cultured alone on 
the well insert were utilised as controls. Four hours before the end of the co-culture period, the 
cultures were processed for [3H]thymidine incorporation and cell counting as described below. 
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[3H]thymidine incorporation 
DNA synthesis was evaluated by measuring the incorporation of radiolabelled nucleotides, in 
trichloroacetic acid precipitable fraction of the cells, after a short time exposure of the cells 
(less than the half of their doubling time) to the factors under investigation. This allows to 
evaluate the rate of DNA synthesis in the absence of significant modifications of cell number, 
which, however, is verified at the end of the incubation period. For the evaluation of the 
incorporation of [methyl-3H]thymidine ([3H]TdR) (Amersham, Milan, Italy), the cells were 
seeded in 24 wells/plates (50000 cells/well). Three days later the media were changed with 
fresh medium with or without FBS, 48 h later the medium was replaced with control medium 
or glial cell- conditioned media. A pulse of [3H]TdR (10 µCi/ml ) was added 20 hours after the 
beginning of the various treatments and left in the culture medium for 4 h. After then, the cells 
were washed with 0.5 ml of Dulbecco's PBS prewarmed to 37°C, fixed with 1 ml of ice-cold 
10% trichloroacetic acid and 10 min later lysed with 0.1 ml of 6N NaOH. A parallel set of 
wells from the same plate were processed as for [3H]TdR incorporation and the cell number 
evaluated at the end of the washing procedure. The cell lysate were then collected and mixed 
with 7 ml of scintillation cocktail (Instagel®, Packard, Milano, Italy) and counted in a 
scintillator for beta emitters (TriCarb 6000, Packard) having a 60% of efficiency. 
 
Evaluation of cells viability 
The number of cells, counted using an hemocytometer, and the cell viability have been taken 
as the measure of cell proliferation and survival in long term experiments. To this purpose, 
SH-SY5Y cells were seeded in 24 wells/plates (30000 cells/well) three days later the media 
were changed with control medium or type 1 astrocytes -conditioned medium (A1-CM). The 
media were changed every three days throughout the period of treatment. The amount of 
viable cells was measured by counting the cells with an hemocytometer after trypan blue stain 
or by using the diphenyl-tetrazolium salt (MTT) procedure (Manthorpe et al., 1986). Briefly, 
cells exposed to the various treatments were washed with warm culture medium and incubated 
for 1 h at 37°C with a solution of MTT (1 mg/ml)(Sigma Chemicals, St.Louis, MO) dissolved 
in culture medium without FBS and phenol red. The solution was then decanted and 1 ml/ well 
of isopropanol was added to dissolve formazan crystals; the absorbance at 560 nm, determined 
by a microplate spectrophotometer, and subtracted of the blank wells and of the absorbance at 
630 nm was taken as an index of the number of living cells in culture. The linearity of the 
response (r>0.98) of the MTT assay ranged from 0.001 to 0.3 units of absorbance, 
corresponding to 5000 and 250.000 cells/well, respectively. The assay was run in triplicates 
(the coefficient of variation among replicates was less than 10%).  
Each other result presented in this study has been obtained from 3-4 independent experiments 
run in 4 replicates. 
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Statistical analysis 
The results were analysed by ANOVA and adequate post-hoc tests (Student t-test, Dunnett). 
The dose-response curves were analysed by means of a Macintosh version of the program 
ALLFIT (De Lean et al., 1978). 
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RESULTS 
 
The study was initially conducted using confluent rat type 1 astrocytes (A1) and SH-SY5Y 
neuroblastoma cells maintained in co-culture in a two-chamber device, which permits the free 
exchanges of soluble factors without allowing any physical contact between the two cell 
populations (see Materials and Methods). To make sure that the effects observed were due 
directly to factor(s) released from the astrocytes, and not mediated by principles present in the 
foetal bovine serum (FBS), a chemical-defined medium (Sato's medium) was used throughout 
the experiments. 
The results of the co-culture experiments are illustrated in Figure 1. In order to simplify their 
lecture, the data are presented as percent variations vs. the respective controls; however, all 
necessary statistical analyses have been performed on the absolute values. Figure 1 (panel a) 
shows that a 24-h co-culture with A1 significantly inhibits the rate of incorporation of 
[3H]TdR in SH-SY5Y cells when compared to that occurring in neuroblastoma cells cultured 
alone in chemical-defined medium. There were no significant modifications of the number of 
living neuroblastoma cells, evaluated by counting the cells at the end of the 24-h of co-culture, 
using the trypan blue exclusion method (Fig. 1, panel b). This suggests that the observed 
decrease of the incorporation of [3H]TdR is linked to a decrease of DNA synthesis, rather than 
to decrease of the cell viability due to toxic factors released by astrocytes. A more prolonged 
time of co-culture (48 h) with A1 allows the values of [3H]TdR incorporation in SH-SY5Y 
cells to return to control levels (Fig. 1, panel a). After 48 h of co-culture with A1 the number 
of living neuroblastoma cells resulted to be significantly increased vs. controls (Fig. 1, panel 
b). Apparently, DNA synthesis  returns to normal levels allowing cell duplication . 
To reduce the complexity of the experimental model, the subsequent experiments were 
performed by evaluating the incorporation of [3H]TdR in SH-SY5Y cells exposed for 24 h to 
the media in which A1 had been cultured for one day (A1-conditioned medium; A1-CM)(see 
Materials and Methods). As shown in Figure 2 (panel a), a 24-hour treatment of SH-SY5Y 
cells with the fresh A1-CM, used immediately after collection, surprisingly did not induce any 
modification of the incorporation of [3H]TdR.  
The effects, at much longer time intervals (3, 6 and 9 days), of the same A1-CM on the 
viability of neuroblastoma cells were subsequently evaluated. It has been first observed that 
control SH-SY5Y neuroblastoma cells grow up to 6 days after the transfer to a chemically-
defined medium; afterwards the number of viable cells decreases to reach at the longest time 
of observation (9 days) a value significantly lower than that found at 6 days and close to that 
measured at the beginning of the experiment (time 0; Fig. 2, panel b). The visual inspection of 
the cultures showed that this effect was linked to a morphological differentiation of SH-SY5Y 
cells, which is then followed by cell death (data not shown) probably due to the absence, in the 
chemical medium, of trophic factors which support the growth of SH-SY5Y cells. When the 
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neuroblastoma cells have been incubated in freshly collected A1-CM, a significant greater 
number of viable SH-SY5Y cells was observed at any time interval when compared to control 
cells; this effect, already apparent at the 3rd day of incubation, became much more evident at 6 
and 9 days (Fig. 2, panel b). In preliminary experiments, we observed that A1-CM still shows 
its stimulatory activity when applied to SH-SY5Y cells in the presence of FBS (absorbance at 
560nm after 9 days of treatment: Control, 0.21± 0.03; A1-CM, 0.47 ± 0.03, P  < 0.05), 
indicating either the presence of growth stimulatory factors in the A1-CM, which differs from 
those present in FBS, or the possibility of addictive effects between the growth stimulatory 
principles present in A1-CM and in FBS. 
Figure 3 shows that the effect of the A1-CM was dependent on its concentration in the culture 
medium. No morphological differentiation of SH-SY5Y cells treated with A1-CM was 
observed at 3, 6 and 9 days of observation.  
In order to verify the physico-chemical stability of the factor(s) responsible for the effects 
exerted by A1-CM, this CM was heated at 70°C for 20 min, a treatment known to induce 
denaturation of protein secondary structures.  
The results have shown that this treatment did not decrease the activity of A1-CM on SH-
SY5Y cell viability; a curve of growth similar to the one represented in Figure 2b was actually 
obtained (data not shown). However, a significant inhibitory effect on [3H]TdR incorporation, 
similar to that observed in co-culture experiments (see Fig. 1), was found using heat-denatured 
A1-CM (Fig. 4). Serendipitously, similar effects on both cell viability and [3H]TdR 
incorporation have been obtained using A1-CM stored at -20°C for a prolonged time (30 days) 
(Fig. 4). 
 On the basis of these results, it was decided to use, in all further experiments, conditioned 
media which had been stored for at least 30 days at -20°C.  
It was therefore verified whether the effects of the CM on neuroblastoma cells were specific 
for A1, or whether other glial elements (i.e., type 2 astrocytes) might also induce it. SH-SY5Y 
cells were incubated with media conditioned for 24 hours by cultures enriched in A1 or in type 
2 astrocytes. The results obtained show once again that the CM obtained from A1 induces a 
significant decrease of [3H]TdR incorporation at 24 hours, followed by a significant increase 
of the number of viable cells after 6 days of treatment (Table 1). On the contrary, no 
significant effect on either [3H]TdR incorporation or cell viability was observed using the CM 
obtained from type 2 astrocytes (Table 1).   
On the basis of the observation that the decrease of the incorporation of [3H]TdR  in SH-
SY5Y cells treated with A1-CM is followed by an increase of the number of living 
neuroblastoma cells, it was decided to perform a time-course experiments in which the 
incorporation of [3H]TdR in SH-SY5Y cells was evaluated using A1-CM submitted to 30 days 
of freezing, rather than the previously shown co-culture method (see Fig. 1). 
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In agreement with the results reported in Figure 1, it was found that the incorporation of 
[3H]TdR in SH-SY5Y cells treated with undiluted A1-CM is characterised by an inhibitory 
phase evident at 12 hours and which lasts up to 24 hours (Table 2); this is followed by a 
progressive normalisation of this parameter, which returns to control levels 48 hours after the 
beginning of the incubation.  
At this point, it was felt necessary to attempt at least an initial identification of the factor(s) 
involved in the opposite effects (inhibitory on the DNA synthesis and stimulatory on the cell 
survival/proliferation) exerted by the A1-CM on neuroblastoma cells. The physico-chemical 
characteristics (e.g., activation by heating and by freezing) of the factor(s) contained in A1-
CM and responsible of the inhibitory effects, suggested a possible similarity with some 
components of the TGFß superfamily. In fact, TGFß, which may be also synthesised by 
astrocytes <Constam, 1992 #14>, is secreted in an inactive form complexed to a connecting 
glycopeptide which may be removed by physical (freezing or boiling) or chemical (extreme 
pH values) treatments, bringing to the free active form of the growth factor (Barnard et al., 
1990). Consequently, a set of experiments was performed to verify the possible participation 
of TGFß in the inhibitory effects described above. Experiments of immunoneutralisation of the 
frozen A1-CM were performed using a pan-specific antibody, which recognises the major 
forms of TGFßs (see Materials and Methods), since different isoforms of TGFß have been so 
far characterised.   
It has been found that the presence of the antibody totally blocks the inhibitory effect of A1-
CM on [3H]TdR incorporation (Figure 5, panel a) observed in SH-SY5Y cells after a 24-hour 
exposure; however, the same antibody was unable to modify the stimulatory effect of A1-CM 
on SH-SY5Y cell number (Figure 5, panel b). 
11 
DISCUSSION 
 
The results reported in the present paper show that confluent cultures of rat A1 secrete some 
humoral factor(s) which are(is) able to stimulate the survival/proliferation of SH-SY5Y 
neuroblastoma cells, and that this effect is preceded by a transient decrease of DNA synthesis, 
detected measuring [3H]TdR incorporation. Both effects are evident when neuroblastoma cells 
are maintained in co-culture with A1, or are exposed to the conditioned media obtained from 
cultures enriched in A1 (A1-CM) provided this was "activated" by either heating or freezing. 
However, the inhibitory effect on [3H]TdR incorporation appears at short times of observation 
(24 hours) since a normalisation of this parameter is observed at 48 hours; as expected the 
stimulatory effect on cell number is evident only at longer time intervals (2 to 9 days). The 
observation of an increase of SH-SY5Y cell number, in presence of control values of [3H]TdR 
incorporation, after 48 hours of co-culture, may be indicative of an effect of A1-released 
factors on cell duplication and/or on cell survival . 
The rapid inhibitory effect on [3H]TdR incorporation in neuroblastoma cells exerted by A1 is 
specific and not ascribable to a general toxic effect, since this effect was not evident when 
fresh A1-CM or the conditioned media derived from type 2 astrocytes have been used. These 
observations suggest that the decrease of [3H]TdR incorporation is not due to the presence, in 
the conditioned medium, of molecules (e.g., thymidine derivatives or metabolites) which 
would interfere with the uptake, rather than with DNA incorporation of [3H]TdR (Wilson, 
1989). 
The hypothesis that the inhibitory effect exerted by A1-CM on DNA synthesis might be due to 
a TGFß-like molecule was proposed on the basis that elements of the TGFβ family become 
fully active after heating or freezing; this (Barnard et al., 1990) was confirmed by the 
observation that the inhibitory effect was abolished by the presence of an anti-TGFß antibody.  
It is known that rat and mouse astrocytes release in culture various isoforms of TGFß in a 
latent form (Saad et al., 1991; Constam et al., 1992); however, the wide spectrum of the 
antibody used do not allow to identify which TGFß isoform (i. e., TGFß1, ß2, ß3 etc.) is 
directly responsible for the effects observed. The similarity of the results obtained from co-
culture experiments and from those performed using A1-CM lead to believe that the same 
principle is involved; however, the observation that the medium of the co-culture is effective 
as such, while the A1-CM needs to be activated by heating or freezing, deserves some 
comment. It has been found that in heterotypic cell cultures TGFß may be present in free 
active form (Antonelli-Olridge et al., 1989; Sato and Rifkin, 1989); this is easily explained by 
the fact that the release of TGFß-activating enzymes from a cell population may be influenced 
by the other cell line present in the co-culture. 
On the other hand, the data here presented also show that A1 secrete one or more factor(s) able 
to induce a strong stimulatory effects on survival and/or proliferation of neuroblastoma cells. 
In fact, the results obtained from co-culture experiments clearly show that when 
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neuroblastoma cells are in humoral contact with A1, they receive a trophic stimulus. At 
variance with the inhibitory effect on [3H]TdR incorporation, this trophic effect becomes 
evident only after prolonged times of exposure of SH-SY5Y cells to cultures of A1 (2 days), or 
to their conditioned media (3, 6 and 9 days). The factor(s) involved in the stimulatory effects 
are highly active and their effects are still clearly and significantly evident at high dilution. 
This stimulatory effect of A1-CM did not require activation by freezing or heating, and was 
resistant to heat.  
The results obtained from the analysis of the time course of [3H]TdR incorporation show that 
the A1-CM-induced increase of the number of viable cells is not paralleled by an increase of 
thymidine uptake at the shorter time, this may be suggestive of an action of glial factor(s) on 
the survival rather than on the proliferation rate of SH-SY5Y cells. However, in a parallel set 
of experiments, it has been shown that the A1-CM is also able to increase the number of SH-
SY5Y cells during their growth in FBS-supplemented medium, suggesting an addictive effect 
of the astrocytic factor(s) on cell proliferation. 
A first obvious explanation of this effect include the possibility that the same TGFß, able to  
induce an early depression of DNA synthesis, may exerts some stimulatory effect at longer 
times. In fact, even if TGFßs appear to exert a general inhibitory effects on cell growth,  
stimulatory actions of this factor have been also reported; these are probably  indirect, and 
mediated by the induction of other growth factors by the TGFß target cells (Barnard et al., 
1990). However, the data here reported show that the neurotrophic effect exerted by A1-CM 
was not eliminated by the presence of the antibody directed to TGFßs, suggesting that the 
stimulatory effect is not due to this growth factor.  
On the other hand, a linkage with the presence of TGFß might be foreseen, since mannose 6-
phosphate, which is contained in the glycopeptide included in the latent form of TGFß, is 
known to exert a strong proliferative action on SH-SY5Y cells through the interaction with the 
IGF-II receptor (Feldman and Randolph, 1991); work is presently in progress to verify this 
hypothesis.  
It is well known that glial cells synthesise and release neurotrophins, as well as a series of well 
characterised growth factors, cytokines and adhesion factors  (Muller et al., 1995). In addition, 
a series of glia-derived factors active on neuroblastoma cells has been reported. These have 
been named gliostatin (Ueki et al., 1993), Glial Maturating Factor (GMF)(Lim et al., 1987; 
Lim et al., 1989; Lim et al., 1990), pleiotrophin (Wanaka et al., 1993) and human-
Neuroblastoma Growth Inhibitory Factor (Eksioglu et al., 1994). In general, they exert an 
inhibitory effect on neuroblastoma cell proliferation which is usually linked to an induction of 
morphological differentiation (Monard et al., 1973). In the present paper no morphological 
differentiation of SH-SY5Y has been observed; a result similar to that obtained by Hirose and 
co-workers (Hirose et al., 1994)> who have found that the treatment of SH-SY5Y cells for 3 
days with embryonic astrocytes CM did not produce any morphological differentiation of the 
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cells. The explanation of this apparent discrepancies on the effects of glial factors on 
morphological changes may be found in the work of Shea et al. (Shea et al., 1994);  these 
authors have found that the induction of neuritogenesis of neuroblastoma cells by glial CM is 
dependent on the density and the age of the glial cultures, the maximal activity being observed 
in younger and non-confluent cultures. As previously mentioned, in the present study the CM 
was collected from confluent cultures of A1 maintained in serum free medium and therefore 
from cells with a pattern of secretory products which may be different from that of more 
dispersed glial cells. The results here reported have been obtained in experimental conditions 
that are different from those used in other studies quoted above; however, the observation that 
brain metastases of abdominal neuroblastoma effectively occur, suggests that the protocols 
here adopted may be the nearest to the "in vivo" pathological conditions. 
It may be of interest to quote here the finding of humoral factors derived from glial cells (new-
born rat cortical astrocytes and C6 rat glioma cells) which protect cultured mouse 
neuroblastoma cells against glutamate toxicity (Amano et al., 1994), as well as GDNF (Glia 
Derived Neurotrophic Factor), a member of the TGFß superfamily, which has been implicated 
in the survival of midbrain dopaminergic neurons and motoneurons "in vivo" and "in 
vitro"(Lin et al., 1993). More recently, it has also been reported that rat C6 glioma cells release 
factors which may increase the survival of SH-SY5Y cells in serum-deprived medium (Zuo 
and Yu, 1995). However, the different methodological approaches adopted (i.e., tumoral vs. 
normal astrocytes) and the different biochemical characteristics (i.e., heat sensitivity) of the 
factors involved in such effects, make very difficult a direct comparison of the results of the 
present study with those reported in the studies cited above, at least until the factors involved 
will not be characterised. 
In conclusion, the results of the present study, even if they are limited only to the cell models 
adopted, indicate that trophic factors released by astrocytes may exert mainly a stimulatory 
effect on human neuroblastoma cell growth " in vitro"; these factor(s) may therefore exert 
either a permissive (by increasing survival) or a trophic (by increasing proliferation) action. 
The imbalance of the effects of such factors, or the acquired resistance of tumour cells to some 
of them (Johnson et al., 1993), may play a key role in favouring the occurrence of  
neuroblastoma-derived brain metastases. The future identification of the factor(s) involved in 
the trophic effects exerted by A1 on neuroblastoma cells "in vitro" will open new perspectives 
for the understanding of the mechanisms supporting the formation of metastases of this tumour 
in the central nervous system. 
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Table 1 
 
Effect of conditioned media obtained from type 1 and from type 2 astrocytes 
on the incorporation of [3H]TdR in SH-SY5Y cells (24-hour exposure) and 
on their viability (6-day exposure). 
       
Glial cells [3H]TdR 
incorporationa 
viability 
(MTT assay)a 
Type 1 astrocytes    -40 ± 7b     +93 ± 3b 
Type 2 astrocytes    +12 ± 5     -8 ± 1 
 
(a) Values are expressed as mean percent variation ± SD respect to control 
cultures exposed to non-conditioned chemical-defined medium.  
(b) Significant P<0.05 vs. respective controls. 
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Table 2 
 
Time course of [3H]TdR incorporation in SH-SY5Y cells exposed to non-conditioned 
control medium and A1-CM 
 
Time of treatment 
(hours) 
Controla A1-CMa % inhibition 
12  33420 ± 6456  16212 ± 1659b    51.5 
18  44671 ± 1790  21288 ±  750b    52.3 
24  46197 ± 3335  27472 ± 2841b    40.5  
36  50342 ± 7214  37188 ± 1375b    26.1  
48  56494 ± 1556  54807 ± 4307     2.9   
    
(a) Values are expressed as mean of cpm/well ± SD; (b) Significant P<0.05 vs Control 
21 
Figure legends 
 
Figure 1 
Effects of co-culture between SH-SY5Y cells and type 1 astrocytes in chemical-defined 
medium on the [3H]TdR uptake (a) and on the number (b) of SH-SY5Y. Type 1 astrocytes 
have been cultured on 0.45 µm membrane inserts and put in contact with the culture medium 
present in culture wells contained SH-SY5Y cells adherent on the plastic surface. In this 
system only the exchange of soluble signals is possible. The number of living cells was 
evaluated by an hemocytometer and the trypan blue-exclusion test. 
The values represent the mean ± SD of 3 independent experiments run in triplicate.* 
Significant P<0.05 vs control (C). 
 
Figure 2 
Incorporation of [3H]TdR in  SH-SY5Y cells treated with control non-conditioned chemical-
defined medium and fresh A1-CM (a) .  Viability of SH-SY5Y cells maintained for 3, 6 and 9 
days in chemical-defined medium (close symbols) or in the A1-CM (open symbols) (b). The 
amount of viable cells has been evaluated by colorimetric MTT assay (see Materials and 
Methods). 
Values represent  mean ± SD. (* Significant P <  0.05 vs control ). 
 
Figure 3  
Dose-related effect of different dilution of the A1-CM on the proliferation of SH-Y5Y cells 
(9-day exposure). The amount of viable cells has been evaluated by colorimetric MTT assay. 
Values represent  mean ± SD. (* Significant P <  0.05 vs control ). 
 
 
Figure 4  
Incorporation of [3H]TdR in SH-SY5Y cells exposed to non-conditioned chemical-defined 
medium, fresh A1-CM or A1-CM which has been submitted to heating (70°C/ 20 min) or 
prolonged freezing (-20°C/ 30 days).  
Values represent  mean ± SD. (* Significant P <  0.05 vs control ). 
 
Figure 5 
Effects of the presence of an anti-TGFßs antibody (5 µg/ml) on SH-SY5Y cells exposed to 
A1-CM. (a) [3H]TdR incorporation was measured in SH-SY5Y cells exposed for 24 hours to 
non-conditioned chemical-defined medium (control, C) or A1-CM. (b) Cell viability was 
evaluated by colorimetric MTT assay after a 3-day exposure to control medium or A1-CM. 
Values represent the mean ± SD. * Significant P<0.05 vs control (C).  
